Avacta Group Plc (AVCT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Avacta Group Plc (AVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12105
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics that are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It has operations in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

Avacta Group Plc (AVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avacta Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avacta Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avacta Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avacta Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Avacta Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Avacta Group Plc, Medical Equipment, Deal Details 10
Partnerships 10
New England Biolabs Enters into Licensing Agreement with Avacta 10
Two US biotech companies Enter into Licensing Agreement with Avacta 11
FIT Biotech Enters into Agreement with Avacta 12
Avacta Enters into Agreement with Mologic 13
Equity Offering 14
Avacta Group Raises USD15.2 Million in Private Placement of Shares 14
Avacta Group to Raise up to USD34.2 Million in Private Placement of Shares 15
Asset Transactions 16
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 16
Avacta Group Plc – Key Competitors 17
Avacta Group Plc – Key Employees 18
Avacta Group Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Oct 02, 2018: Avacta Group: Preliminary results for the year ending 31 July 2018 21
Apr 16, 2018: Avacta Group Announces Interim Results for the Period Ended 31 January 2018 34
Oct 04, 2017: Avacta Group: Preliminary Results for the Year Ending 31 July 2017 40
Aug 07, 2017: Avacta Group: Trading Update and Notice of Results 41
Apr 03, 2017: Avacta Group: Interim results for the period ended 31 January 2017 43
Corporate Communications 44
Jun 11, 2018: Avacta Group Appointments Dr Eliot Forster As Non-Executive Chairman 44
Mar 29, 2018: Avacta Group Announces Directorate Change 45
Oct 02, 2017: Avacta Establishes US Business Development Team 46
Government and Public Interest 47
Jan 20, 2017: AGM business update and notice of results 47
Product News 48
Oct 11, 2018: Avacta’s Chief Technology Officer to present at major US conference 48
Dec 10, 2017: Avacta to Present Customer Data at Major US Conference 49
Nov 15, 2017: Covance to Present Affimer Data at European Conference 50
May 10, 2017: Avacta Group: Key Affimer patent to be granted in China 51
May 10, 2017: Avacta: Key Affimer patent to be granted in China 52
Apr 03, 2017: Excellent results for Affimer technology in Industry-standard immunogenicity study using human samples 53
Other Significant Developments 54
Jan 18, 2018: Avacta Group: AGM Business Update and Notice of Results 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Avacta Group Plc, Medical Equipment, Key Facts, 2018 2
Avacta Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Avacta Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avacta Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Avacta Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avacta Group Plc, Deals By Market, 2012 to YTD 2018 8
Avacta Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
New England Biolabs Enters into Licensing Agreement with Avacta 10
Two US biotech companies Enter into Licensing Agreement with Avacta 11
FIT Biotech Enters into Agreement with Avacta 12
Avacta Enters into Agreement with Mologic 13
Avacta Group Raises USD15.2 Million in Private Placement of Shares 14
Avacta Group to Raise up to USD34.2 Million in Private Placement of Shares 15
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 16
Avacta Group Plc, Key Competitors 17
Avacta Group Plc, Key Employees 18
Avacta Group Plc, Other Locations 19
Avacta Group Plc, Subsidiaries 19

List of Figures
Avacta Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Avacta Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Avacta Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Avacta Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Avacta Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Avacta Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Avacta Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Avacta Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Avacta Group Plc (AVCT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務情報
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sunac China Holdings Ltd:戦略・SWOT・企業財務分析
    Sunac China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunac China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cryostar SAS:企業の戦略的SWOT分析
    Cryostar SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • QVC Inc:企業の戦略的SWOT分析
    QVC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析
    MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SciBase AB (SCIB):医療機器:M&Aディール及び事業提携情報
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務情報
    Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PathoQuest SAS-医療機器分野:企業M&A・提携分析
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that offers game changing metagenomics approach to improve the breadth of pathogen detection. The company offers automated bioinformatics software that provide comprehensive pathogens database to produce microbiome reports. Its testing a …
  • Avisa Pharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic di …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Takeda Pharmaceuticals International AG-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals International AG (Takeda), a subsidiary of Takeda Pharmaceutical Company Ltd is a developer, manufacturer and distributor of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, canc …
  • Bank of Hawaii Corp (BOH):企業の財務・戦略的SWOT分析
    Bank of Hawaii Corp (BOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Shandong Airlines Co., Ltd.:企業の戦略・SWOT・財務分析
    Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • NovaBay Pharmaceuticals Inc (NBY):企業の財務・戦略的SWOT分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • UNIQA Bulgaria:企業の戦略・SWOT・財務情報
    UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report Summary UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Exelon Generation Company LLC:企業の戦略的SWOT分析
    Exelon Generation Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆